1,711 results on '"Schaefer, E.J."'
Search Results
2. Relationship between dietary vitamin D intake, obesity, and twenty lipoprotein subclasses: Results from the Kyushu and Okinawa Population Study (KOPS)
3. Effects of margarines and butter consumption on lipid profiles, inflammation markers and lipid transfer to HDL particles in free-living subjects with the metabolic syndrome
4. Atherogenic lipoproteins and carotid intimal medial thickness progression over 5 years
5. Atherogenic lipoproteins and atherosclerotic cardiovascular disease in the Framingham offspring study
6. First international descriptive and interventional survey for cholesterol and non-cholesterol sterol determination by gas- and liquid- chromatography–Urgent need for harmonisation of analytical methods
7. The effect of quality and amount of dietary fat on the susceptibility of low density lipoprotein to oxidation in subjects with impaired glucose tolerance
8. Phenotype Of Definite Familial Hypercholesterolemia With Negative Genetic Study In Argentina
9. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters
10. Interaction between the Hepatic Lipase 514(C/T) Polymorphism and Dietary Fat Intake Modulates HDL-C Levels and HDL Subfractions: The Framingham Heart Study
11. The ABCA1 gene variant and heart disease risk reduction in the elderly during pravastatin treatment
12. C-REACTIVE PROTEIN AND GENETIC VARIANTS AND COGNITIVE DECLINE IN OLD AGE: THE PROSPER STUDY
13. C-Reactive protein and genetic variants and cognitive decline in old age: the PROSPER Study
14. Genetic Variation at the NPC1L1 Gene Locus, Plasma Lipoproteins, and Heart Disease Risk in the Elderly
15. Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial
16. Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia
17. Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.
18. Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.
19. Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia
20. SMALL DENSE LDL CHOLESTEROL, HDL PARTICLES, INSULIN, ADIPONECTIN, AND GLYCATED ALBUMEN AS PROSPECTIVE CHD RISK FACTORS IN THE FRAMINGHAM STUDY
21. VARIATION AT THE LDLR GENE IS ASSOCIATED WITH PLASMA LIPID LEVELS AND CHD IN THE PROSPER STUDY
22. Th-P16:395 Effects of maximal statin therapy on the high density lipoprotein (HDL) subpopulation profiles of hypercholesterolemic subjects
23. Th-PL4:4 Nutrition and heart disease: Where are we?
24. Mo-W1:1 Effects of cholesteryl ester transfer protein inhibition on lipoprotein metabolism in humans
25. Th-P16:376 ABCG5/8 and NPC1L1 polymorphisms and response to pravastatin in prosper
26. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: A randomized trial
27. Association Between the PPARA L162V Polymorphism and Plasma Lipid Levels
28. Interaction between the hepatic lipase −514(C/T) polymorphism and dietary fat intake determines HDL-C levels and HDL subfractions: the Framingham Offspring study
29. Fasting and postprandial remnant-like particle cholesterol and triglycerides are elevated in patients with coronary heart disease
30. Association between the PPARA L162V polymorphism and plasma lipid levels. Interactions with the APOE, APOC3 and LPL Loci: the Framingham offspring study
31. Impact of hydrogenated fat on high density lipoprotein subfractions and metabolism
32. Biomass and Aggregation Analysis of Human Embryonic Kidney 293 Suspension Cell Cultures by Particle Size Measurement
33. Similarity of cruzin, an inhibitor of Trypanosoma cruzi neuraminidase, to high-density lipoprotein
34. 3. High-density lipoprotein as a coronary heart disease risk factor and gene mutations affecting high-density lipoprotein cholesterol levels: results from the Framingham Heart Study
35. 1.W04.5 Lipids and lipoproteins as risk factors for atherosclerosis: New biochemical and genetic markers
36. 4.P.240 Statin therapy reduces concentrations of remnant-like particles
37. 1.W05.3 Common mutations in the lipoprotein lipase gene influence plasma lipids and prevalence of coronary heart disease
38. 2.P.160 A comparison of lipoprotein (a)-cholesterol levels and sinking prebeta lipoprol with heart disease risk in the Framingham heart study
39. Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men.
40. Lovastatin inhibits diet induced atherosclerosis in F1B Golden Syrian hamsters
41. Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol.
42. Homozygous Tangier disease and cardiovascular disease
43. The MspI restriction fragment length polymorphism 3′ to the apolipoprotein A-II gene: relationships with lipids, apolipoproteins, and premature coronary artery disease
44. Alzheimer's Disease and Suicide: An Integrative Literature Review.
45. Influence of Placentation on High Density Lipoproteins in Adult Males: The NHLBI Twin Study
46. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus Relationships with lipids, apolipoproteins, and premature coronary artery disease
47. Role of integrin αvβ[sub3] in the production of recombinant adenoviruses in HEK-293 cells.
48. "OMICS" in Human Milk: Focus on Biological Effects on Bone Homeostasis.
49. Endothelial Dysfunction with Aging: Does Sex Matter?
50. Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.